Jeffrey Weitzel MD
Professor of Oncology and Population Sciences Dr. Norman & Melinda Payson Professorship in Medical Oncology Founder, Division of Clinical Cancer Genomics City of Hope Cancer Center 1500 East Duarte Road Duarte, CA 91010
Join to View Full Profile
4000 Cambridge StKansas City, KS 66160
Phone+1 913-588-6656
Dr. Weitzel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Medical Genetics and Genomics, 1994 - 1996- Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1992
University of MinnesotaResidency, Internal Medicine, 1983 - 1986- University of Minnesota Medical SchoolClass of 1983
Certifications & Licensure
CA State Medical License 1996 - 2026
KS State Medical License 2024 - 2025
MN State Medical License 1985 - 2025
AZ State Medical License 2000 - 2015
MA State Medical License 1986 - 1997
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Conquer Cancer Research Professorship in Breast Cancer Disparities ASCO Conquer Cancer Foundation
- America's Top Doctors Castle Connolly, 2004-2020
- American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education American Society of Human Genetics, 2019
- Join now to see all
Clinical Trials
- Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease Start of enrollment: 2004 Mar 11
- Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer Start of enrollment: 2010 Jun 30
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer Start of enrollment: 2010 Sep 03
- Join now to see all
Publications & Presentations
PubMed
- A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.Anton Safonov, Tomoki T Nomakuchi, Elizabeth Chao, Carrie Horton, Jill S Dolinsky
Nature Communications. 2025-04-01 - 1 citationsPathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast.Huaizhi Huang, Ronan E Couch, Rachid Karam, Chunling Hu, Nicholas Boddicker
Clinical Cancer Research. 2025-01-06 - Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk.Sarah S Kalia, Nicholas J Boddicker, Siddhartha Yadav, Hongyan Huang, Jie Na
Cancer Epidemiology, Biomarkers & Prevention. 2024-11-01
Press Mentions
Gov. Newsom Should Release Vulnerable PrisonersJuly 8th, 2020- City of Hope Physicians Present Innovative Cancer Research at ASCO20 Virtual SessionMay 30th, 2020
City of Hope to Lead National Research Aimed at Improving testing/treatment for Devastating Cancer-Causing SyndromeNovember 22nd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
